Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1400 participants
INTERVENTIONAL
2024-01-26
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. VOCs levels were measured at baseline in healthy people, and markers of VOCs that could be used to identify acute cardiogenic chest pain were sought.
2. The relationship between abnormal VOCs (mainly aldehydes) and prognosis of patients and the correlation with Super-score for early warning of acute heart failure.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vital Signs Monitoring of Emergency Responders in Different States
NCT06076057
Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients
NCT01470274
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
NCT04490317
Quality of Care in Centers Providing Extracorporeal Membrane Oxygenation
NCT05331001
Heart Rate Variability in Extracorporeal Membrane Oxygenation (ECMO) Patients
NCT01247727
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cardiogenic chest pain group
cardiogenic chest pain group/acute coronary syndrome
VOCs
test the end-expiratory gas
normal group
Healthy population
VOCs
test the end-expiratory gas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VOCs
test the end-expiratory gas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with acute cardiogenic chest pain (see diagnostic criteria);
3. Patient\'s informed consent.
1. Over 18 years old, male or female;
2. Centerless cerebrovascular disease, lung disease, no abnormal liver and kidney function, no acute infection recently;
3. Informed consent.
Exclusion Criteria
2. Patients with terminal illness or receiving palliative care;
3. Have participated in other clinical studies or consider it inappropriate to participate in this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu hospital
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KYLL-202401-047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.